Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Physical measures versus cabergoline for lactation inhibition
RBR-3cbzwyNot yet recruiting
- Sponsor
- IMIP
- Start
- Jul 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of cabergoline in lactation suppression (2 arms), sponsored by IMIP. Planned start Jul 2018; status: not yet recruiting.
02
Drugs
cabergoline
03
Conditions
lactation suppression
Beyond the preview
Go deeper on RBR-3cbzwy.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-3cbzwy.